Under conventional culture conditions, smooth muscle cells display their phenotypic modulation from a differentiated to a dedifferentiated state. Here, we established a primary culture system of smooth muscle cells maintaining a differentiated phenotype, as characterized by expression of smooth muscle-specific marker genes such as h-caldesmon and calponin, cell morphology, and ligand-induced contractility. Laminin retarded the progression of dedifferentiation of smooth muscle cells. Insulin-like growth factors (IGF-I and IGF-II) and insulin markedly prolonged the differentiated phenotype, with IGF-I being the more potent. In contrast, serum, epidermal growth factor, transforming growth factors, and platelet-derived growth factors potently induced dedifferentiation compared with angiotensin II, arginine-vasopressin, and basic fibroblast growth factor. Using the present culture system, we investigated signaling pathways regulating a phenotype of smooth muscle cells. In cultured cells, IGF-I specifically activated phosphatidylinositol 3-kinase (PI3-kinase) and its downstream target, protein kinase B, but not mitogen-activated protein kinases. Specific inhibitors of PI3-kinase (wortmannin and LY294002) induced dedifferentiation of smooth muscle cells even when they were cultured on laminin under IGF-I-stimulated conditions. The sole effect of laminin to retard the dedifferentiation was completely blocked by anti-IGF-I antibody, and laminin promoted the endogenous expression of IGF-I in cultured cells. The reduced promoter activity of the caldesmon gene induced by platelet-derived growth factor BB was overcome by the forced expression of the constitutive active form of PI3-kinase p110␣ catalytic subunit. These findings suggest that an IGF-I signaling pathway through PI3-kinase plays a critical role in maintaining a differentiated phenotype of smooth muscle cells.
The smooth muscle cells (SMCs) 1 play roles in the control of blood pressure, enteric peristalsis, and bronchial, uterus, and bladder contraction. Although the precursor cells of SMC seem to undergo phenotypic modulation into matured cells, the origin of precursor cells has not been well characterized. During embryogenesis, three different lineages (cardiac neural crest, nodosa placode, and lateral mesoderm) have been, in part, proven as precursors of SMC. In the case of vasculogenesis (1, 2) , angioblasts originated from mesoderm differentiate into endothelial cells, which then coalesce to form a single layer of endothelial tubes. It has been proposed that these primitive vessels are involved in the recruitment of neighboring mesenchymal cells and the subsequent differentiation of SMCs. However, the precise mechanism regarding recruitment of SMC precursors has remained unknown. Phenotypic modulation of SMCs is also associated with pathological conditions, such as atherosclerosis, hypertension, and leiomyogenic tumorigenicity. In the progression of these diseases, SMCs change their phenotype from a differentiated to a dedifferentiated state (3) . Recent studies have focused on the molecular mechanism of SMC phenotype-dependent expression and/or isoform conversion of ␣-SM actin (4, 5) , smooth muscle myosin heavy chain (6, 7) , ␣-and ␤-tropomyosins (8, 9) , calponin (10, 11) , SM22␣ (10, 11) , h-caldesmon (9, 12) , and ␣1 integrin (13, 14) . These proteins, which are specifically expressed in SMCs, are collectively termed as SMC-specific molecular markers. The expressions of ␣-SM actin, caldesmon, calponin, SM22␣, ␤-tropomyosin, smooth muscle myosin heavy chain, and ␣1 integrin are increased in differentiated SMCs but are decreased in dedifferentiated SMCs. These changes are regulated at transcription levels. Isoform changes of caldesmon, ␣-tropomyosin, and smooth muscle myosin heavy chain are controlled by alternative splicing in an SMC phenotype-dependent manner.
Changes to these molecular markers are, therefore, favorable for quantification to SMC phenotypes (15) . In order to elucidate the molecular mechanism of such phenotypic modulation, it is necessary to use cultured SMCs. However, the SMCs in conventional culture display their phenotype from a differentiated to a dedifferentiated state (16) . In addition, passaged SMCs do not show a differentiated phenotype even if they are cultured under quiescent conditions. Serum growth factors and extracellular matrices (ECMs) have been reported to be involved in such phenotypic modulation. Using morphological criteria, Hedin et al. (17) demonstrated that in primary cultured vascular SMCs, laminin induced a delay in the progression of dedifferentiation, whereas fibronectin stimulated it. There are some reports regarding the establishment of cell lines that display partial characteristics of differentiated SMCs as monitored by morphological and biochemical indicators. Despite these efforts, primary culture systems or cell lines of SMC maintaining a differentiated phenotype have not been presented. Here, we achieved the first establishment of a primary culture system of SMCs to maintain a differentiated phenotype for a long culture using SMC-specific molecular markers, cell morphology, and ligand-induced contractility as indicators. We confirmed that laminin retarded the progression of SMC dedifferentiation and found that insulin-like growth factor-I (IGF-I) had a highly potent activity to maintain a differentiated phenotype. Using these culture conditions, we investigated the IGF-I-generated signaling pathway in SMCs and demonstrated the critical role of phosphatidylinositol 3-kinase (PI3-kinase) in maintaining a differentiated phenotype. This culture system seems to be useful for future analyses of SMC-specific signal transduction and transcription and for identification of factors affecting the SMC phenotype.
MATERIALS AND METHODS
Antibodies-Anti-PI3-kinase p85 subunit antiserum and monoclonal anti-IGF-I antibody, which can neutralize the activity of IGF-I, were purchased from Upstate Biotechnology. Polyclonal antibodies against mitogen-activated protein kinases (MAPKs), such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal protein kinase (JNK), p38MAPK, Akt/protein kinase B (PKB), and PI3-kinase p110␣ subunit were obtained from Santa Cruz Biotechnology.
Plasmids-Construction of caldesmon promoter plasmid, GP3CAT, is described elsewhere (12) . Expression plasmid of a constitutive active form of PI3-kinase p110␣ subunit was kindly provided by Drs. H. Kurosu and T. Katada (Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo). This cDNA was constructed by Hu et al. as described previously (18) and was inserted downstream of the cytomegalovirus promoter of pCMV5.
Cell Culture-Gizzard SMCs in primary culture were prepared from 15-day old chick embryos. Whole gizzards were dissected under sterile conditions, and tunica muscularis was carefully separated from serosa and tunica mucosa. The gizzard muscles were minced well with scissors and were incubated at 30°C in 1 mg/ml collagenase (type V, Sigma) solution containing 137 mM NaCl, 5 mM KCl, 4 mM NaHCO 3 , 2 mM MgCl 2 , 5.5 mM D-glucose, 10 mM PIPES, pH 6.5, and 0.2% bovine serum albumin (BSA) for 60 min with gentle shaking (19) . Dispersed single cells were separated from undigested tissues by filtration and were collected by centrifugation at 800 rpm for 5 min at 4°C. The cells thus obtained were washed twice with basal culture medium (Dulbecco's modified Eagle's medium (DMEM) supplemented with 0.2% BSA) and were cultured in the medium on 6-well culture plates (1 ϫ 10 6 cells/3.6-cm 2 well) coated with ECM components (laminin, fibronectin, and collagen type I or collagen type IV) at 37°C with 5% CO 2 atmosphere. The coating of the wells with ECM components was performed as follows: the wells were soaked with solutions containing laminin or fibronectin (20 g/ml in phosphate-buffered saline (PBS), Iwaki Glass, Chiba, Japan) or collagen type I or type VI (20 g/ml in 0.1 mM HCl, Iwaki Glass) at room temperature for 3 h. After washing with PBS, the wells were soaked with DMEM containing 0.2% BSA to block nonspecific binding. The cultured cells were stimulated with indicated amounts of growth factors, cytokines, and/or kinase inhibitors on the first day of culture, and the medium was changed at an interval of 2 days. The medium containing wortmannin was replaced every 6 h throughout the culture period (20) .
Ligand-induced contractility of cultured SMCs was analyzed as follows. SMCs were cultured under IGF-I-or PDGF-BB-stimulated conditions for 3 days, and the cultures were washed with PBS and then stimulated with basal culture medium containing 1 mM carbachol for 1 min. Contraction was observed with a microscope, and the same fields of vision before and after carbachol treatment (1 min) were photographed.
Northern Blotting-Total RNAs were extracted from precultured or cultured SMCs under indicated conditions using an ISOGEN RNA extraction kit (Nippon Gene, Japan). Two micrograms of total RNAs were separated on 1.0% agarose-formaldehyde denaturing gels and then transferred to nylon membranes. A caldesmon cDNA (GenBank TM accession number M28417) fragment (expanding from 286 to 810) and a calponin cDNA (GenBank accession number M63559) fragment (expanding from 1 to 867) were used as probes to monitor the expression of respective mRNA. This caldesmon cDNA fragment, composed of parts of exon 2 and exon 3a is a common probe for h-and l-caldesmon (21, 22) . In previous studies, we demonstrated using specific probes for h-or l-caldesmon that the full lengths of h-and l-caldesmon mRNAs are 4.8 and 4.1 kilobases, respectively (9, 14) . Probes were 32 P-labeled on the antisense strands and used for hybridization under the following conditions: at 42°C for 16 h in 50% formamide, 6ϫ SSC, 10ϫ Denhardt's solution (1ϫ Denhardt's solution is 0.02% polyvinylpyrrolidone/0.02% BSA), 0.5% SDS, and 0.5 mg/ml denatured herring sperm DNA. The blots were washed in 0.1ϫ SSC containing 0.1% SDS at 52°C and visualized by autoradiography. The ratio of h-caldesmon mRNA versus total h-and l-caldesmon mRNAs and the content of calponin mRNA were quantified by Scanning Imager (Molecular Dynamics). To quantify the applied RNAs, ribosomal RNAs were stained with 0.02% methylene blue.
Immunoblotting-After washing with PBS, the indicated cultured SMCs were lysed with 2% SDS sample buffer. The protein samples were separated by SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Detection of target proteins on the membrane was performed by ECL Western blotting detection kit (Amersham Pharmacia Biotech) using the respective polyclonal antibodies against caldesmon (23) and calponin (24) . The anti-calponin antibody was donated by Dr. K. Hiwada.
Reverse Transcription-Polymerase Chain Reaction (PCR) AnalysisEndogenous IGF-I mRNA in SMCs was analyzed by reverse transcription-PCR based on the contents of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Total RNAs were extracted from precultured and cultured SMCs under the indicated conditions, and oligo(dT) 15 primed single-strand cDNAs were synthesized from 3 g of total RNAs using RAV-2 reverse transcriptase (Takara). Heat-treated single-strand cDNA mixtures were subjected to PCR using specific sets of primers (see the legend to Fig. 6 ) and ExTaq DNA polymerase (Takara) under the following conditions: 96°C for 3 min once and 28 cycles of 94°C for 1 min, 62°C for 1.5 min, and 72°C for 1.5 min for IGF-I mRNA, and 96°C for 3 min once and 18 cycles of 94°C for 1 min, 56°C for 2 min, and 72°C for 2 min for GAPDH mRNA. We confirmed that PCR cycle numbers were pertinent because PCR products were saturated under 30 cycles for IGF-I mRNA and 20 cycles for GAPDH mRNA (data not shown). PCR products were separated on 1.2% agarose gels, and then transferred to nylon membranes. The membranes were hybridized with oligoprobes (see the legend to Fig. 6 ) to detect IGF-I and GAPDH cDNAs under the following conditions: at 45°C for 16 h in 6ϫ SSC, 10ϫ Denhardt's solution, 0.5% SDS, and 0.5 mg/ml denatured herring sperm DNA. The blots were washed in 6ϫ SSC containing 0.1% SDS at 50°C. Quantification of amplified IGF-I and GAPDH cDNA were carried out as described for Northern blotting, and the ratios of IGF-I cDNA content were normalized to GAPDH cDNA contents.
PI3 Kinase Assay-Phospholipid mixtures containing phosphatidylinositol (PI) and phosphatidylserine (PS) were dried under a stream of nitrogen and sonicated (2 mg/ml) in 10 mM HEPES (pH 7.4) in a bath sonicator at 0°C for 15 min. Ten microliters of the vesicles (PI/PS) was used as a substrate for PI3-kinase. Preparation of cell lysates and immunoprecipitation for PI3 kinase were conducted at 4°C. The cultured cells were washed three times with ice-cold PBS, and the cells were lysed in 550 l of lysis buffer (20 mM Tris-HCl, pH 7.5, 137 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 1% Nonidet P-40, 50 mM NaF, 1 mM Na 3 VO 4 , 50 g/ml phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, and 1 g/ml pepstatin). After 30 min of gentle shaking, the lysates were centrifuged in a microcentrifuge at 13,000 rpm for 5 min. The amounts of PI3-kinase p85 subunit in the cell lysates were estimated by Western blotting using antiserum against PI3-kinase p85 subunit (Upstate Biotechnology). The lysates containing equal amounts of PI3-kinase p85 subunit were precleaned with control rabbit IgG coupled protein ASepharose for 30 min. PI3-kinase was immunoprecipitated with antiserum against PI3-kinase p85 subunit (Upstate Biotechnology) and protein A-Sepharose. The immunoprecipitates were washed twice with the lysis buffer; twice with 100 mM Tris-HCl, pH 7.5, 0.5 M LiCl, 1 mM DTT, and 0.2 mM Na 3 VO 4 ; and three times with 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM DTT, and 0.2 mM Na 3 VO 4 . All washes were performed at 4°C. The reaction mixtures (50 l) containing the immunoprecipitates in 20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM MgCl 2 , 0.5 mM EGTA, 10 M ATP, 5 Ci [␥-
32 P]ATP, and 20 g of PI/PS were incubated at 30°C for 10 min. The reactions were terminated, and the lipids were extracted by the addition of CHCl 3 /MeOH (1: 2) and mixing. The mixture was vortexed and centrifuged. The extracted reaction products were separated by thin-layer chromatography by a developing solution composed of CHCl 3 /MeOH/4 M NH 4 OH (9:7:2). The production of phosphatidylinositol-3-phosphate was observed by autoradiography.
Other Protein Kinase Assays-Basic methods were similar to that for PI3-kinase assay. Cell lysis buffer comprised 50 mM Tris-HCl (pH 7.5), 120 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 50 mM NaF, 1 mM Na 3 VO 4 , 10 mM ␤-glycerophosphate, 50 g/ml phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, and 1 g/ml pepstatin for ERK and Akt/PKB; 20 mM Tris-HCl, pH 7.5, 10% glycerol, 1 mM DTT, 120 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 50 mM NaF, 1 mM Na 3 VO 4 , 10 mM ␤-glycerophosphate, 50 g/ml phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, and 1 g/ml pepstatin for JNK; and 20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM EDTA, 1% Triton X-100, 50 mM NaF, 2 mM Na 3 VO 4 , 10 mM ␤-glycerophosphate, 50 g/ml phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, and 1 g/ml pepstatin for p38MAPK. The cell lysates were immunoprecipitated with specific antibodies against the respective protein kinases, and the immunoprecipitates were washed well with their lysis buffer and then with kinase assay buffer and incubated with respective specific substrates and 5 Ci [␥ 32 P]ATP for 30 min at 30°C. The reaction products were analyzed by 15% SDS-PAGE. Kinase reaction mixtures were as follows: 50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 1 M protein kinase A inhibitor, 1 mM DTT, and 25 g of histone H2B for Akt/PKB; 50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 1 M protein kinase A inhibitor, 1 mM DTT, and 25 g of myelin basic protein for ERK; 50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 1 M protein kinase A inhibitor, 1 mM DTT, 1 mM Na 3 VO 4 , and 1 g of glutathione S-transferase-Jun (1-79) for JNK; and 20 mM HEPES, pH 7.4, 20 mM MgCl 2 , 20 mM ␤-glycerophosphate, 1 M protein kinase A inhibitor, 2 mM DTT, and 1 g of glutathione S-transferase-ATF2 (1-96) for p38MAPK.
Promoter Analysis-Caldesmon promoter was analyzed using chloramphenicol acetyltransferase (CAT) construct, GP3CAT (12) , according to the method described elsewhere (12, 14) . The SMCs prepared as described above were seeded on laminin-coated 6-well plates and were cultured in DMEM supplemented with 0.2% BSA or in the medium containing 20 ng/ml PDGF-BB for 3 days. Transfection was carried out on 3-day culture using Trans IT TM -LT1, polyamine transfection reagents (Pan Vera Corporation). Complex mixtures composed of 10 g of trans-IT TM -LT1 reagent and 2 g of GP3CAT, 1 g of control plasmid carrying the luciferase gene under Rous sarcoma virus promoter (Rous sarcoma virus-luciferase), and 2 g of control expression plasmid (pCMV5) or expression plasmid carrying a constitutive active form of PI3-kinase p110␣ subunit were added to the cells in Opti-MEM (Life Technologies, Inc.). Following a further 4-h incubation, the medium was replaced with DMEM supplemented with 0.2% BSA plus 2 ng/ml IGF-I or 20 ng/ml PDGF-BB, and the transfected cells were harvested 48 h later. Standardization of transfection efficiency was performed using luciferase activity as described previously (12, 14) . Cell extracts containing equal amounts of luciferase activity were used for CAT assay. The transfection experiments were repeated at least three times on duplicate cultures with two or three different plasmid preparations. The CAT activity was quantified by Scanning Imager (Molecular Dynamics).
RESULTS

Effects of ECMs on a Phenotype of Cultured SMCs-Under
conventional culture conditions, SMCs prepared by either enzyme dispersion or explant methods rapidly display phenotypic modulation from a differentiated to a dedifferentiated state (16) . It has been suggested that ECMs play, at least in part, a role in the determination of SMC phenotype. Using SMC-specific molecular markers (caldesmon, calponin, ␣-and ␤-tropomyosins, and ␣1 integrin), we examined the culture conditions of SMCs using ECM components such as laminin, fibronectin, and collagens type I and type IV, which are present in the SMC layer. The expression of such SMC-specific molecular markers at mRNA levels represented a phenotype of SMCs; h-caldesmon and ␣-tropomyosin were converted to l-caldesmon and F1 and F2 tropomyosins, respectively. Calponin, ␤-tropomyosin, and ␣-integrin were also down-regulated during dedifferentiation (data not shown). Among them, we selected caldesmon and calponin as molecular markers for SMC phenotype (Fig. 1) . In SMCs cultured on laminin, isoform conversion of caldesmon and down-regulation of total caldesmon (h-plus l-caldesmons) and calponin were significantly observed at 5 days of culture, and these changes proceeded thereafter. By contrast, such changes in the expression of marker genes occurred on the first day of SMCs cultured on the other three ECM components. These results indicated that laminin, but not other ECM components, retarded the dedifferentiation of SMCs.
IGF-I Is a Highly Potent Factor to Maintain a Differentiated Phenotype of SMCs-Although laminin retarded the dedifferentiation of SMCs, it was not able to maintain a differentiated phenotype for more than 5 days of culture (Fig. 1) , suggesting the requirement of additional factors. We further examined the effects of several growth factors and cytokines on SMCs cultured on laminin (Fig. 2) . Dedifferentiation of SMCs was induced by serum and several growth factors/cytokines such as platelet-derived growth factors (PDGFs), basic fibroblast growth factor, angiotensin II, arginine-vasopressin, epidermal growth factor (EGF), and transforming growth factors (TGF␤s). These factors induced the conversion of h-caldesmon to l-caldesmon and the decrease of the calponin expression. Among them, serum, EGF, TGF␤s, and PDGFs potently induced dedifferentiation compared with angiotensin II, arginine-vasopressin, and basic fibroblast growth factor; the former factors completely induced the conversion of h-caldesmon to l-caldesmon and the down-regulation of the calponin expression to a negligible level at 5 days of culture ( Fig. 2A, lanes 2-4  and 8 -13) . EGF, TGF␤s, and PDGFs significantly decreased the expression of caldesmon ( Fig. 2A, lanes 9 -13) , whereas the down-regulation of caldesmon by serum (Fig. 2A, lane 8) was modest. On the other hand, IGF-I, IGF-II, and insulin prolonged the differentiated phenotype of SMCs for more than 9 days of culture, as determined by the expression of h-caldesmon and calponin mRNAs ( Fig. 2A, lanes 5-7, 14, and 15-17 ) and the proteins (Fig. 2B, lanes 1-4) . The same results were obtained using ␣-and ␤-tropomyosins and ␣1 integrin as other SMC-specific molecular markers (data not shown).
To determine which is the most potent factor for maintaining a differentiated state of SMCs, we compared dose dependence among IGFs and insulin (Fig. 3) . The concentrations of IGF-I, IGF-II, and insulin required for half-maximum levels of hcaldesmon expression (the ratio of h-caldesmon mRNA to total h-and l-caldesmon mRNAs is 50%) were 6.5 ϫ 10 Ϫ13 , 2.7 ϫ 10 Ϫ12 , and 2.2 ϫ 10 Ϫ11 M, respectively (Fig. 3A) . In regard to calponin, the concentrations of IGF-I, IGF-II, and insulin required for half-maximum levels were 1.3 ϫ 10 Ϫ12 , 2.7 ϫ 10 Ϫ12 , and 1.7 ϫ 10 Ϫ10 M, respectively (Fig. 3B) . These results suggest that IGF-I is 2-4 times and 34 -130 times more potent than IGF-II and insulin, respectively. We also confirmed by immunoblotting that IGF-I receptor protein was expressed in SMCs and that its expression was not affected by stimulation of IGF-I, serum, or PDGF-BB (data not shown).
In addition to these SMC-specific molecular markers, SMCs cultured on laminin under IGF-I-stimulated conditions appeared as a spindle-like shape and formed a typical meshwork. They also displayed a carbachol-induced contractility (Fig. 4, A  and C) . In contrast, SMCs cultured under PDGF-BB-stimulated conditions showed a fibroblast-like shape and were unable to contract (Fig. 4, B and D) . Based on three criteria, such as biochemical markers, cell morphology, and ligand-induced contractility, we concluded that our culture system as presented here made it possible to maintain a differentiated phenotype of SMCs for a long culture.
Biological Significance of Laminin on SMCs-We then investigated the effect of laminin on cultured SMCs (Fig. 5) . Anti-IGF-I monoclonal antibody, which can neutralize the activity of IGF-I, abolished the effect of laminin to retard the dedifferentiation of SMCs under nonstimulated conditions (Fig. 5, lanes 1-3) and the effect of IGF-I to maintain a differentiated phenotype of SMCs cultured on laminin (lanes 4 -6) . h-Caldesmon was converted to l-caldesmon in addition to the significant down-regulation of its expression. At the same time, the expression of calponin was also drastically decreased (Fig.  5, lanes 1 and 4) . These results suggest that the effect of laminin on SMCs is mediated through the action of IGF-I, which minimally affects the phenotype. To confirm this, we carried out reverse transcription-PCR analysis to compare the IGF-I expression in SMCs cultured on laminin, fibronectin, and collagens type I and type IV (Fig. 6) . At early culture days (1-day to 3-day culture), IGF-I mRNA contents in SMCs cultured on laminin were 3-5-fold higher than those in SMCs cultured on other ECM components. The effect of laminin on enhanced IGF-I mRNA synthesis was observed to last for 9 days of culture (data not shown). As shown in Fig. 3 , IGF-I concentration required for half-maximum levels of the expression of h-caldesmon and calponin mRNAs was 6.5 ϫ 10 Ϫ13 to 1.3 ϫ 10 Ϫ12 M. Exogenous IGF-I (1.3 ϫ 10 Ϫ11 M) made it possible to maintain half-maximum levels of the marker gene expression in SMCs cultured on other ECM components (data not shown). Considering these findings, we speculate that the amounts of IGF-I secreted from SMCs cultured on laminin would be 1.2 ϫ 10 Ϫ11 M. Under a large excess of IGF-I (2.6 ϫ 10 Ϫ9 M), SMCs were able to maintain a differentiated state even when they were cultured on other ECM components (data not shown). Thus, IGF-I is absolutely essential for the maintenance of a differentiated state.
PI3-Kinase Generated by IGF-I Is a Major Signaling Pathway Maintaining Differentiated
SMCs-As demonstrated here, IGF-I plays a vital role in maintaining a differentiated phenotype of SMCs. To characterize the signaling pathways generated from IGF-I, we analyzed several kinases involved in signal transduction: PI3-kinase, Akt/PKB, and MAPKs. IGF-I potently activated PI3-kinase and also its downstream target, Akt/PKB. PI3-kinase was maximally activated at 10 min after IGF-I stimulation, and its activity gradually decreased there- 1-13) and 9-day (lanes 15-17) cultured SMCs on laminin under indicated growth factor-, cytokine-, or nonstimulated conditions, and they were analyzed by Northern blotting or probed with caldesmon and calponin cDNA fragments, respectively. B, the expressions of caldesmon and calponin proteins were analyzed by immunoblotting in precultured SMCs (lane 1) and 9-day cultured SMCs under indicated growth factor stimulated conditions (lanes 2-4) . Anti-caldesmon antibodies reacted with both h-and l-caldesmons. after (Fig. 7A, lanes 1-6) , whereas activation of Akt/PKB lasted for more than 3 h (Fig. 7B, lanes 1-4) . In SMCs stimulated with IGF-I, activation of ERK and stress-activated MAPKs, JNK, and p38MAPK was not observed (Fig. 7, C-E) . Activation of PI3-kinase and Akt/PKB was significantly suppressed by specific PI3-kinase inhibitors, LY294002 and wortmannin (Fig.  7A, lanes 7-10, and 7B, lanes 5-8) , suggesting that activation of Akt/PKB depends on PI3-kinase activity. Based on these findings, we further examined the effect of the PI3-kinase inhibitors on a phenotype of SMCs cultured on laminin under IGF-I-stimulated conditions. Both PI3-kinase inhibitors induced isoform conversion of caldesmon and down-regulation of caldesmon and calponin in a dose-dependent manner (Fig. 8,  lanes 1-7) , indicating that SMC phenotype was mediated by these inhibitors. These drugs also inhibited the sole effect of laminin to retard the dedifferentiation of SMCs (data not shown). The specific inhibitors for the ERK signaling pathway, PD98059, and for p38MAPK, SB203580, did not affect on a phenotype of differentiated SMCs maintained by IGF-I as determined by caldesmon and calponin mRNAs (Fig. 8, lanes 8  and 9) . p70 ribosomal S6 kinase (p70S6K) is one of the downstream targets of PI3 kinase and Akt/PKB (25) . Rapamycin, a specific inhibitor of p70S6K, had also no effect on differentiated SMCs (Fig. 8, lane 10) . These results suggest that PI3-kinase is a major downstream target of IGF-I signaling in SMCs and plays an important role in maintaining a differentiated state of SMCs. As shown in Fig. 2 , EGF, TGF␤s, and PDGFs decreased the expression of caldesmon concomitant with the down-regulation of calponin. We then carried out a promoter analysis using a CAT construct inserted in the caldesmon promoter region into the upstream of CAT gene, GP3CAT (12) , to confirm the functional involvement of PI3-kinase in transcriptional regulation of the caldesmon gene. We previously reported that GP3CAT produced high promoter activity in differentiated SMCs (12) . Consistent with the data in Fig. 8 , the promoter activity of GP3CAT was dramatically decreased by LY294002 (Fig. 9, columns 1 and 2) . In 3-day culture of SMCs stimulated with PDGF-BB, the expression of caldesmon was potently down-regulated (Fig. 2, lane 13) . The promoter activity was also reduced to 50% of that in SMCs stimulated with IGF-I (Fig. 9, column 3) . This reduction could be overcome by the forced expression of the constitutive active form of PI3-kinase p110␣ catalytic subunit (18) (Fig. 9, column 4) . These findings indicate that PI3-kinase is involved in maintaining a differentiated phenotype of SMCs and that activation of caldesmon promoter also depends on the PI3-kinase signaling pathway.
DISCUSSION
Under conventional culture conditions, SMCs convert their phenotype from a differentiated to a dedifferentiated state (16) . During dedifferentiation, the SMC irreversibly changes its morphology from a long spindle-like to a proliferative fibroblast-like shape and loses the expression of SMC-specific 1-3 and 7) or IGF-I (0.26 nM)-stimulated (lanes 4 -6) conditions. Anti-IGF-I antibody (5 g/ml) (lanes 1 and 4) or equal amounts of control mouse IgG (lanes 2 and 5) were added to the culture medium.
marker genes and its ligand-induced contractility. To our knowledge, there have been no reports regarding the establishment of primary culture systems or clonal cell lines of SMC that can control its own phenotype. As monitored by SMCspecific molecular markers, cell morphology, and function, we achieved the first establishment of a primary culture system of SMCs maintaining a differentiated phenotype by a combination of IGF-I and laminin. Using this culture system, we demonstrated that PI3-kinase activation by IGF-I is a key signaling event involved in maintenance of a differentiated phenotype of SMCs.
As shown in Fig. 2 , IGF-I, IGF-II, and insulin prolonged the differentiated phenotype of SMCs. Among them, IGF-1 was the most potent factor (Fig. 3) . Because the order of concentrations of IGFs and insulin required for maintenance of half-maximum expression levels of caldesmon and calponin genes was IGF-I Ͻ IGF-II Ͻ Ͻ insulin, the effects of these growth factors would be mediated through IGF-I receptor. It has been reported that in cultured vascular SMCs, IGF-I stimulates SMC proliferation and migration (26 -29) . Balloon denaturation of the rat aorta results in a 7-fold increase in IGF-I expression, and this increase is closely associated with cell growth (30) . Antisense transcripts of IGF-I receptor cDNA inhibit vascular SMC growth (31) . This accumulated evidence suggests that IGF-I is a factor inducing cell growth and/or migration in vascular SMCs. On the other hand, in our culture system of visceral SMCs, IGF-I was the most potent factor maintaining a differentiated phenotype, but it is not involved in dedifferentiation characterized by cell growth and migration. This discrepancy would be due to a difference in the origin of the SMCs or experimental conditions. In fact, vascular SMCs reported by previous investigators have been passaged under serum-stimulated conditions. The response to IGF-I in these cells would be changed by serum-induced phenotypic modulation. Additionally, our culture conditions are in part applicable for vascular SMCs. Therefore, a difference in experimental conditions is a likely cause of the discrepancy.
Using a variety of cell lines, it has been well studied that binding of IGF-I to its receptor activates the intrinsic tyrosine kinase activity of the IGF-I receptor, resulting in autophosphorylation of its own receptor and phosphorylation of target molecules such as insulin receptor substrate-1 and Shc proteins (32, 33) . Multiple phosphotyrosine sites in insulin receptor substrate-1 serve as binding sites of various signaling molecules, including PI3-kinase (34) . Stimulation of PI3-kinase leads to the activation of downstream signaling molecules, including Akt/PKB and p70S6K (25) . PI3-kinase also directly interacts with the PDGF receptor. The Shc proteins have specific tyrosine phosphorylation sites to associate with Grb2 and the GTP-binding protein Ras (35, 36) . However, these are no reports regarding the IGF-I generated signaling in SMCs. In this study, we found in our culture system that IGF-I enhanced PI3-kinase and Akt/PKB activities and that these activations were completely blocked by wortmannin and LY294002 (Fig. 7,  A and B) . Consistent with this, the PI3-kinase inhibitors induced the dedifferentiation of SMCs cultured on laminin under IGF-I stimulated conditions (Fig. 8) . Forced activation of PI3-kinase further resulted in an increase in the promoter activity of caldesmon gene in dedifferentiated SMCs induced by PDGF-BB (Fig. 9) . In contrast, IGF-I did not activate the signaling pathways through MAPKs (Fig. 7, C-E) . These results suggest that a signaling pathway of PI3-kinase plays a crucial role in maintaining a differentiated phenotype of SMC. At present, we have not yet characterized the downstream signaling molecules of PI3-kinase, except for Akt/PKB. Because the activity of Akt/PKB was potentiated by IGF-I stimulation in a PI3-kinase-dependent manner and activation of this kinase lasted for more than 3 h (Fig. 7B) , this kinase would be one of the downstream targets of PI3-kinase. It is now necessary to reveal whether Akt/PKB is functionally involved in phenotypic modulation of SMC and to identify the further downstream targets. Rapamycin did not affect a differentiated phenotype of SMCs cultured on laminin under IGF-I stimulated conditions (Fig. 8) , indicating that p70S6K would not be involved in this signaling. As demonstrated here, the signaling pathway from IGF-I to PI3-kinase plays a key role in maintaining a differentiated phenotype of SMCs. IGF-I-stimulation was, however, not able to convert a dedifferentiated state of SMCs to a differentiated state even when IGF-I receptor was fully expressed (data not shown). Therefore, the signaling pathway inducing differentiation of SMCs would be different from that maintaining a differentiated phenotype.
Regarding the effect of laminin on SMCs, laminin enhanced endogenous expression and secretion of IGF-I. This finding is based on the inhibitory effect of neutralizing anti-IGF-I antibody, endogenous expression of IGF-I mRNAs (Figs. 5 and 6) , and semi-estimation of IGF-I in cultured medium for maintaining the expression of SMC-specific marker genes. The effect of laminin mediated through endogenous expression and secretion of IGF-I on differentiated SMCs was abolished by the specific PI3-kinase inhibitors wortmannin and LY294002 (data not shown). These observations suggest that a low level of endogenously produced IGF-I might contribute to delay the dedifferentiation. It has been previously reported that laminin delayed the progression of dedifferentiation of primary cultured vascular SMCs, whereas fibronectin stimulates it (17) . Such an effect of laminin on cultured vascular SMCs might be due to the enhanced production and secretion of IGF-I by laminin.
In this paper, we established for the first time a culture system of visceral SMCs maintaining a differentiated state for a long culture. This culture system may be applicable for vas- FIG. 6 . Expression of endogenous IGF-I mRNA in SMCs cultured on laminin, fibronectin, collagen type I, and collagen type VI. Total RNAs were extracted from precultured SMCs and 1-day and 3-day cultures of SMCs on ECM components under nonstimulated conditions. Then, single-strand cDNAs were synthesized as described under "Materials and Methods." Primer sets used for PCR were as follows: IGF-I mRNA, AATCAGAGCAGATAGAGCCTGC (sense primer, nucleotide numbers 97-118) and CAGCAAAGTACTCTGCA-GATGG (antisense primer, corresponding to nucleotides 741-765) (GenBank accession numbers M32791 and M29720); GAPDH, CTG-GCAAAGTCCAAGTGGTG (sense primer, nucleotide numbers 124 -143) and CATAAGACCCTCCACAATGC (antisense primer, corresponding to nucleotides 556 -575) (GenBank accession number K01458). PCR products separated by 1.2% agarose gel electrophoresis were transferred to nylon membranes, followed by probed with oligonucleotides to detect cDNA fragments of IGF-I and GAPDH: IGF-I, TTGGAGCACAG-TACATCTCCAG (antisense primer, corresponding to nucleotide numbers 619 -640); GAPDH, GGCCAAGGGTGCCAGGC (antisense primer, corresponding to nucleotides 517-523). ECM components and culture days were indicated at the top: LN, laminin; FN, fibronectin; Col-I, collagen type I; and Col-IV, collagen type IV. cular SMCs. Furthermore, the SMC culture system presented here is useful for analyzing SMC-specific molecular events, such as signal transduction and gene regulation, including transcription and splicing. In this paper, we showed a partial characterization of caldesmon gene expression in association with signaling pathways (Fig. 9) . Using the present culture system, we are currently conducting detailed analyses of the gene regulation of SMC-specific markers and screening of novel factors involved in phenotypic modulation of SMCs. Information obtained by this culture system should be effective in clarifying the molecular mechanism of SMC phenotypic determination, including vascular and visceral SMCs. The cells were lysed and subjected to PI3-kinase assays as described under "Materials and Methods." To confirm the amounts of PI3-kinase p85 regulatory subunit in the cell lysates used for kinase assay, we performed immunoblotting probed with antiserum against PI3-kinase p85 subunit. The top and bottom panels are the results of kinase assay and immunoblotting (IB), respectively. B, Akt/PKB assay; C, ERK assay; D, JNK assay; and E, p38MAPK assay. In these protein kinase assays, the cells were stimulated with 0.26 nM IGF-I for indicated times (lanes 1-4 in B-E 3 and 4) . GP3CAT was co-transfected with Rsv-Luciferase and a control plasmid (pCMV5) (columns 1-3 ) or pCMV5p110␣Act carrying a constitutive active form of PI3-kinase p110␣ subunit (column 4). Promoter activity was assayed at 48 h after transfection as described under "Materials and Methods." Relative promoter activities were normalized to the activity in SMCs cultured under IGF-I-stimulated conditions as 100%. Each value represents the average and S.D. of at least three independent experiments. Promoterless control CAT plasmid, pUC0CAT, did not show a detectable CAT activity under respective conditions (data not shown). B, PI3-kinase activities in SMCs transfected with pCMV5p110␣Act (lane 1) and control plasmid pCMV5 (lane 2).
